Announcements Trials

Browse Landscape

Phase

Status

Completed 2 Terminated 1 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Stomach Neoplasms 1 Lung Neoplasms 1 Diarrhea 1 Colonic Polyps 1 Colonic Neoplasms 1 Colitis, Ulcerative 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma 1 Breast Neoplasms, Male 1 Breast Neoplasms 1 Barrett Esophagus 1 Adenocarcinoma of Lung 1

Interventions

Capecitabine 27 pembrolizumab 19 Oxaliplatin 19 Fluorouracil 17 Cisplatin 17 Trastuzumab 14 Docetaxel 14 Leucovorin 11 Paclitaxel 8 Irinotecan 8 S 1 (combination) 7 Epirubicin 6 Cyclophosphamide 5 tegafur-gimeracil-oteracil 4 aldesleukin 4 Hyperthermic Intraperitoneal Chemotherapy 4 titanium silicide 3 spartalizumab 3 fludarabine phosphate 3 fludarabine 3 Surveys and Questionnaires 3 Surgical Procedures, Operative 3 Ramucirumab 3 Nivolumab 3 Indocyanine Green 3 Gemcitabine 3 Carboplatin 3 Albumin-Bound Paclitaxel 3 Ado-Trastuzumab Emtansine 3 vistusertib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Stomach Neoplasms × Endoscopy × Clear all

NCT01727908 2019-09-16

FamGaCan

Radboud University Medical Center

Phase NA Terminated

Gastrointestinal

Carcinoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡